The impact of COVID-19 pandemic on technologic and process innovation in point-of-care diagnostics for sexually transmitted infections
Research article
[키워드] accelerate
Amendment
AMRantimicrobial resistance
antimicrobial resistance
Chlamydia trachomatis
CLIAClinical Laboratory Improvement Amendments
clinical
Clinical Laboratory Improvement Amendments
Coronavirus disease 2019
COVID-19
COVID-19 pandemic
COVID-19coronavirus disease 2019
CTChlamydia trachomatis
described
diagnostic
diagnostics
Emergency use
Emergency use authorization
EUAemergency use authorization
FDA
FDAFood and Drug Administration
Food and Drug Administration
HIVhuman immunodeficiency virus
Human immunodeficiency virus
improvement
Infection
lab
LMICLow- and middle-income countries
Low- and middle-income countries
measure
movement
Neisseria gonorrhoeae
NGNeisseria gonorrhoeae
OTCover-the-counter
over-the-counter
PCRpolymerase chain reaction
platform
POC
POC test
POCpoint-of-care
point-of-care
polymerase chain reaction
public health messaging
RADxRapid Acceleration of Diagnostics
Rapid Acceleration of Diagnostics
sexually transmitted infection
STIsexually transmitted infection
transmitted
WHOWorld Health Organization
World Health Organization
[DOI] 10.1016/j.clinbiochem.2021.11.003 [Article Type] Research article
[DOI] 10.1016/j.clinbiochem.2021.11.003 [Article Type] Research article